For thousands of people around the world with a bleeding disorder, access to basic care is a daily challenge. The WFH Humanitarian Aid Program aims to address this problem by providing patients—including children—with the support they need to lead normal lives. Thanks to the multi-year factor donations provided by our partners, people with bleeding disorders in the developing world have continued access to treatment for emergency situations, acute bleeds, corrective surgeries, and prophylaxis for young children.
Want to learn more about the WFH Humanitarian Aid Program? Have a look at some of our resources here:
- Watch the WFH Humanitarian Aid Program session at the WFH
- Learn about the impacts the Program had in in 2019
- Download the 2019 WFH Humanitarian Aid Program Impact Report
- Discover stories about the Program’s successes around the world
About the WFH Humanitarian Aid Program
The WFH Humanitarian Aid Program improves the lack of access to care and treatment by providing much-needed support for people with inherited bleeding disorders in developing countries. By providing patients with a more predictable and sustainable flow of humanitarian aid donations, the WFH Humanitarian Aid Program makes it possible for patients to receive consistent and reliable access to treatment and care. None of this would be possible without the generous support of Sanofi Genzyme and Sobi, our Founding Visionary Contributors; Bayer, our Visionary Contributor; Grifols and Roche, our Leadership Contributors; and our Contributor, CSL Behring. To learn more about the WFH Humanitarian Aid Program, visit www.treatmentforall.org.